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Abstract
In this research note we examine the biomedical publication output about Ebola
in 2014. We show that the volume of publications has dramatically increased in
the past year. The rise reflects an impressive growth starting in the month of
August, concomitant with or following the surge in infections, deaths and
coverage in news and social media. Though non-research articles have been
the major contributors to this growth, there has been a substantial increase in
original research articles too, including many papers of basic science. The
United States has been the country with the highest number of research
articles, followed by Canada and the United Kingdom. We present a
comprehensive set of charts and facts that, by describing the volumes and
nature of publications in 2014, show how the scientific community has
responded to the Ebola outbreak and how it might respond to future similar
global threats and media events. This information will assist scholars and
policymakers in their efforts to improve scientific research policies with the goal
of maximizing both public health and knowledge advancement.
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Introduction
The Ebola outbreak that has affected West Africa for over a year has 
captured the attention of audiences throughout the world. Much has 
been said and written about this tragic event in the popular media as 
well as in scientific journals1–11. The scientific community has cer-
tainly vigorously debated about the Ebola outbreak. However, no 
study has so far assessed the impact of the current African epidemic 
on scientific production. In this research note we try to fill this gap 
by examining the volume and nature of the biomedical publication 
output about Ebola in 2014. We believe this study is important as it 
may lead to insights as to how the global scientific and health com-
munities react to these kinds of events. The note looks at general 
trends in Ebola-related publications, at the type of papers that were 
published and at the extent to which countries have contributed to 
the Ebola literature. This information will be useful to researchers 
and policymakers aspiring to increase the impact of scientists’ work 
on public health as well as on the pure advancement of knowledge.
Methods and data
Searching criteria
All searches were performed in PubMed (http://www.ncbi.nlm.nih.
gov/pubmed/), a public search engine maintained by the United 
States National Library of Medicine (NLM) at the National Insti-
tutes of Health (NIH) that provides access to over 24 million cita-
tions in all fields of life sciences, mostly from the MEDLINE 
(Medical Literature Analysis and retrieval System Online) database. 
To calculate the number of publications on Ebola in 2014, we ran a 
search by using the ‘custom range’ function set to 2014 publications 
and searched for ‘ebola OR ebolavirus’ in ‘all fields’, in ‘title/abstract’ 
field or in ‘title’ field. We retrieved, respectively, 945, 900 and 797 
citations (Figure S1) (sheet 1). We also ran the search using the 
‘MeSH major topic’ filter and retrieved 945 citations (sheet 1). 
Upon reviewing the results, we noticed that some citations retrieved 
when searching only in ‘all fields’ or ‘title/abstract’ or by using the 
‘MeSH’ filter were not publications discussing some specific aspect 
of Ebola; for this reason, we decided to only use the 797 citations 
retrieved with searches in the title. Throughout the paper we will 
therefore not specify the search field and use title as the default 
option. We also searched for ‘ebola’ and ‘ebolavirus’ separately. We 
retrieved 778 and 19 citations, respectively (Figure S2) (sheet 1). 
Given that both ‘ebola’ and ‘ebolavirus’ were used in publications 
titles, we decided henceforth to use ‘ebola OR ebolavirus’ as the 
default search term.




Ebola publications output 1995–2014
To determine recent trends on publications, we looked at the publica-
tions record on Ebola for the past 20 years (from 1995 to 2014). Using 
the ‘custom range’ function, we retrieved a total of 1869 citations. 
A year-by-year analysis shows that while the publication output did 
not differ substantially from 1995 to 2013, there was a staggering 
increase in publication output in 2014 as evidenced by the fact that 
42.6% of all the papers published during the time period 1995–2014 
were published in the last year alone (Figure S3) (sheet 2).
We then determined the number of publications with an abstract 
available. As research articles or research notes usually have an 
abstract but editorials, commentaries, short letters and several 
other types of publication usually do not, the publications with an 
abstract better reflect the real output in original research papers. 
We observed again a remarkable increase in the year 2014, which 
had 23.3% of all publications of the last 20 years. In particular, the 
publications with an abstract available in 2014 were almost 5 times 
the publications with an abstract available in 2013 (Figure S4) 
(sheet 2). Interestingly, the proportion of publications with an avail-
able abstract in 2014 was considerably lower than in all the previ-
ous years: for example, while in 2013 the proportion was 92.4%, 
in 2014 it was only 32.9% (Figure S5) (sheet 2). Given that an 
abstract, when present, is usually made available at the same time 
the article appears in PubMed, these results indicate that the major-
ity of publications in 2014, differently from the previous years, 
were non-research papers.
Analysis by ‘article type’
To determine the article types of 2014 Ebola publications we first 
used the ‘article types’ filters of PubMed. ‘Comments’ were 4.3%, 
‘editorials’ 11.0%, ‘interviews’ 1.1%, ‘journal articles’ 57.5%, ‘letters’ 
10.4%, ‘news’ 20.5% and ‘reviews’ 2.0% (Figure S6) (sheet 3) (note 
that the sum of percentages is more than 100% because PubMed 
can assign multiple classifications to the same article). Even if these 
filters lead to results that may not always be corresponding to the 
type of items that appears in the database (not all publications are 
assigned to a PubMed ‘article type’), these numbers indicate the 
presence of many citations that were not original research arti-
cles. By searching for only abstract available citations, we instead 
obtained very different numbers. ‘Comments’ were 0.8%, ‘edito-
rials’ 0.8%, ‘interviews’ 0.4%, ‘journal articles’ 96.6%, ‘letters’ 
0%, ‘news’ 2.3% and ‘reviews’ 5.7% (Figure S7) (sheet 3). These 
numbers show, as expected, that the vast majority of publications 
with an abstract available did not belong to the categories of short 
articles like editorials but instead belonged to the ‘journal article’ 
category.
Analysis by text availability
We then examined three other features: the language, full text avail-
ability and the citations in PubMed Commons. By using the English 
language filter, we found that 94.9% of the publications were writ-
ten in English. By using the ‘abstract available’, the ‘full text’ and 
the ‘free full text’ filters we determined that 32.9% of publications 
had the abstract available, 94.1% had the full text available (either 
for a fee or at no charge) and 25.7% had the full text available at no 
charge. Only 0.4% of the publications had comments in PubMed 
Commons (Figure S8) (sheet 3). By repeating the same searches 
with publications with an abstract available, we observed that 
96.2% of the articles were written in English, 100% (as obvious) 
had an abstract available, 93.5% had the full text available (either 
for a fee or at no charge) and 42.7% had the full text available at 
no charge. Again only 0.4% had comments in PubMed Commons 
(Figure S9) (sheet 3).
We also analyzed the language, text availability and PubMed Com-
mons citations only for the ‘journal articles’. 94.8% of these cita-
tions were written in English, 55.2% had an abstract available, 
93.2% had the full text available (either for a fee or at no charge) 
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and 35.6% had the full text available at no charge. Only 0.7% had 
comments in PubMed Commons (Figure S10) (sheet 3).
These results show that most of the publications on Ebola in 2014 
did not have an abstract and therefore can be safely classified as 
non-research papers. Moreover they show that, similarly to the case 
with biomedical publications in general, almost all the citations had 
a full text available but only in less than half of the cases the text is 
freely available at present. These data also show that while 96.6% of 
the publications with an abstract available were ‘journal articles’, only 
55.2% of the ‘journal articles’ had an abstract available (Figure S11) 
(sheet 3). Based on this evidence we conclude that abstract avail-
ability is most likely a better criterion than the ‘journal article’ to 
estimate which publications are original research papers.
Focus analysis by use of search terms
To analyze the particular focus of the retrieved papers, we searched 
for specific terms in the title/abstract field. We first searched for 
terms related to cell and molecular biology like ‘cell’, ‘molecule’, 
‘protein’, ‘antibody’, ‘gene’ and ‘genome’. We also searched for the 
terms ‘drug’ and ‘vaccine’. All these terms were searched for both 
the singular and the plural form. The proportions of papers with 
these terms ranged from 2.0% (for the term ‘gene’) to 9.7% (for 
the term ‘vaccine’). The term ‘drug’ appeared in 4.5% of the papers 
(Figure S12) (sheet 4). We then repeated the analysis with terms 
more specifically related to the 2014 West Africa outbreak. In par-
ticular, we searched for ‘outbreak’, ‘africa’, ‘liberia’, ‘sierra leone’, 
‘guinea’, ‘nigeria’, ‘preparedness’. These terms were present in 
21.5%, 22.0%, 7.4%, 7.9%, 7.5%, 2.8% and 4.5% of the papers, 
respectively (Figure S13) (sheet 4).
We then repeated the analyses by taking in consideration only the 
publications with an abstract available. As expected, the proportions 
of papers with these terms were higher. The terms ‘drug’ and ‘vac-
cine’ were in the 6.5% and 20.6% of the publications, respectively 
(Figure S14) (sheet 4). The terms ‘outbreak’, ‘africa’, ‘liberia’, 
‘sierra leone’, ‘guinea’, ‘nigeria’, ‘preparedness’ were in 45.4%, 
46.2%, 19.8%, 19.8%, 21.4%, 7.6% and 9.2% of the publications 
with an abstract available, respectively (Figure S15) (sheet 4). As 
the word Africa was present in almost half of the papers with an 
abstract available, these results suggest, as expected, that the sharp 
increase in publications in 2014 was driven mostly by the West 
Africa outbreak. This was also confirmed by the fact that the years 
2012 and 2013 had much lower proportions of papers containing 
the term ‘Africa’ in the title/abstract (in particular, by performing 
whole year analyses, we retrieved 9 papers in 2012, 4 in 2013 and 
187 in 2014; with regard to publications with an abstract available, 
7 papers in 2012, 4 in 2013 and 132 in 2014). Liberia, Sierra Leone 
and Guinea, the three countries with the most cases of infections, 
were present in the title or abstract with very similar proportions 
near to 20% whereas Nigeria, the fourth most affected country but 
much less affected than the first three, was present in title or abstract 
of less than 10% of the publications.
Analysis of clinical trial study publications
To obtain the numbers of publications of clinical trials, we used 
the ‘clinical trial’ filter of PubMed. However, the search led to zero 
result: no 2014 publication on Ebola was tagged as clinical trial 
publication. However, this filter of PubMed may not be totally 
accurate because some clinical trial studies may not be assigned to 
the ‘clinical trial’ category. Therefore, we also searched for the term 
‘clinical trial’ in the title/abstract field. We retrieved 4 publications. 
Among these, 3 had an abstract available. As the presence of the 
search term in the title/abstract does not imply that the publication 
is in fact about a clinical trial, we examined the content of the 4 
retrieved publications. We observed that only 2 publications were 
actually reports of an original clinical trial (Figure S16) (sheet 4).
Ebola publications timeline during 2014
We also analyzed the publication trends within 2014. To this pur-
pose we calculated the volumes of publications for each month of 
2014 by using the ‘custom range’ function (for January, we did not 
include January 1st as this would have included a few undetermined 
publications). In the case of papers published online before the 
print version, we considered the date of the online publication. As 
shown in Figure S17 (sheet 5), the vast majority of publications 
were published after the month of August, with a peak in the month 
of October and a plateau-like pattern during the last three months 
of the year. We performed the same analysis also with the publica-
tions with an abstract available. We obtained very similar results, 
with a peak in the months of October and November (Figure S18) 
(sheet 5). These results indicate that the increase in publications 
(both research and non-research papers) only started at the end of 
the summer of 2014, concomitant with the surge in infection and 
death cases and more intense reports on part of the mass media.
Focus analysis by subjective classification
We further investigated the focus of the 2014 publication output by 
performing a subject-matter analysis. By looking at the title and the 
abstract, we determined the proportion of papers that had a relevant 
focus towards one or more aspects of the current 2014 outbreak. 
We found out that a high proportion (40.5%) of all citations had 
focused on some aspects of the West Africa epidemic (Figure S19) 
(sheet 5). Most of these publications were reports of the epidemic or 
articles about preparedness or the international response to the crisis. 
With regard to the other publications, we assigned them to one of 
the following categories: ‘cell/molecular biology’, ‘drugs/antibodies/ 
vaccines’, ‘pathophysiology/epidemiology/ecology’, ‘preparedness’, 
‘society/policy/ethics’ or ‘other’. Even if many papers could be 
assigned to more than one category, each paper was assigned only 
to the most applicable category. All papers focusing on drugs/anti-
bodies/vaccines were assigned to the ‘drugs/antibodies/vaccines’ 
even if many of these could belong also to the ‘cell/molecular biol-
ogy’ category. We observed that the category with more hits was 
‘preparedness’ with 35.1% of the papers, followed by ‘pathophysi-
ology/epidemiology/ecology’ (18.8%), ‘drugs/antibodies/vaccines’ 
(18.0%), ‘society/policy/ethics’ (15.0%), ‘cell/molecular biology’ 
(10.0%) and ‘other’ (3.2%) (Figure S19) (sheet 5). We also ana-
lyzed the distribution of these categories on a monthly basis; we 
observed that the categories ‘outbreak’ and ‘preparedness’ increased 
substantially after August, with ‘outbreak’ peaking in October and 
‘preparedness’ peaking in November. The other categories also 
increased considerably after August. The category with the smallest 
growth was ‘cell/molecular biology’; this is not surprising as this is 
the category that is the least directly connected to the current Africa 
events (Figure S20) (sheet 5).
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In order to corroborate this classification by subject-matter, we also 
used objective parameters by examining the monthly distribution of 
papers containing specific terms. We analyzed the monthly distribu-
tion of papers with the terms ‘outbreak’, ‘africa’ or ‘vaccine’ in the 
title/abstract (see Figure S12–Figure S15) (sheet 4) and found that 
the distribution patterns of papers for ‘outbreak’, ‘africa’ and ‘vac-
cine’ were similar to the patterns obtained with the subject-matter 
and subjective classification. In particular, the papers with the term 
‘outbreak’ peaked in October and had a distribution very similar 
to the subject-matter category (Figure S21–Figure S23) (sheet 5). 
These results show that the majority of papers published in 2014 
were either about the West Africa epidemic or about general prepar-
edness topics. Nonetheless, all discipline/area categories substan-
tially increased during the last part of the year, including papers of 
basic cell and molecular biology research.
Analysis of publications by country
We analyzed the Ebola publications by country. To this end, we 
used a previously used method12 that relies on the affiliation field 
provided by PubMed to determine the affiliation country of authors. 
Before 2013 this method could be used to determine the affiliation 
country based on the first author only. However, starting from 2014, 
PubMed provides for most of citations information about every 
author. Thus, in 2014 this method could be used to quantify the 
number of papers with at least one author (any author, not only the 
first one) with a reported affiliation in a given country12. Using this 
method, we calculated the Ebola publications for the 20 countries 
with most publications12 (the United States was the country with most 
total biomedical publications, with almost 20,000 citations in the 
year 2014, followed by China and the United Kingdom (Figure S24) 
(sheet 6)). The United States was the country with by far the most 
Ebola publications (122 citations), followed by the United Kingdom 
(64), France (35) and Canada (31) (Figure 25) (sheet 6). We also 
calculated the ‘attraction scores’ for the same 20 countries. These 
scores are a measure of the relative focus towards a topic/field and 
are calculated by dividing the topic/field-relevant papers by the total 
number of biomedical papers for the same country (and multiplying 
by 10,000)12. The ‘attractions scores’ of the 20 countries were very 
different, as expected by the different patterns of total and Ebola 
only papers (Figure S24–Figure S25) (sheet 6). The country with 
the highest ‘attraction score’ was the United Kingdom, followed by 
France, Canada and Switzerland (Figure S26) (sheet 6).
We then repeated the same analyses by taking in consideration only 
the papers with an abstract available. If one looks at all biomedical 
publications, the proportion of publications with an abstract avail-
able was very high (on average 91.3%), with very little variabil-
ity (relative standard deviation was 3.1%) (Figure S27) (sheet 6). 
If compared to Ebola-only papers, this number is very high. In fact, 
only 32.9% of the Ebola papers contained an abstract (see Figure S8) 
(sheet 3). This shows that, in 2014, the proportions of publications 
types on Ebola were different from those of the average biomedical 
publication.
We then looked at the only publications with an abstract available 
(the United States was the country with most total biomedical publi-
cations, with over 180,000 citations, followed by China, the United 
Kingdom and Germany (Figure S28) (sheet 6). The proportion of 
Ebola publications attributed to the United States (79 citations) 
was even higher than in the case of all types of publications, fol-
lowed by Canada (21) and the United Kingdom (18) (Figure S29) 
(sheet 6). Canada was in this case the country with the highest ‘attrac-
tion score’, followed by the United States and France (Figure S30) 
(sheet 6).
We finally assessed the accuracy of our method by scrutinizing the 
six countries with most Ebola publications (Figure S31) (sheet 7). 
We looked at the affiliation information of all the papers with an 
abstract available published by these countries to determine if any 
author from those countries was indeed present. As a matter of fact, 
100% of the 155 analyzed papers had at least one author with at 
least one affiliation from the searched country; this result proved 
the accuracy of the method. We then determined the numbers of 
first and last authors with an affiliation in the searched country. 
With regard to the first author, we observed that in 73.6% of the 
papers she/he was from the searched country (China had the largest 
proportion (84.6%) and Canada the smallest proportion (61.9%)). 
With regard to the last author, we observed that in 73.9% of the 
papers she/he was from the searched country (the United States had 
the largest proportion (90.0%) and Canada had the smallest propor-
tion (57.1%)) (Figure S32) (sheet 7) (see also USA, UK, France, 
Canada, China, Germany sheets).
A closer look at the focus of publications from the United 
States and Canada
We took a closer look at the 101 papers with an abstract available 
published by the United States and Canada - the two countries with 
most citations with an abstract available. We first examined the arti-
cle types and found that the vast majority of papers with an abstract 
available from the United States or Canada were research papers 
(average 68.3%). Reviews were the second category (average 
23.8%). The sum of all the other categories (like commentaries and 
editorials) was less than 8% of the papers with an abstract available 
(Figure S33) (sheet 8). These results indicate that the vast majority 
of papers with an abstract available were indeed research publica-
tions; also, they reveal that the quantity of reviews was higher than 
the one determined by the ‘review’ filter managed by PubMed.
We then examined the area/field of the same set of 101 publications. 
As before, we assigned papers to different categories based on the 
discipline/area of study focus. We observed that 29.7% were about 
basic ‘cell/molecular biology’, 27.7% about ‘drugs/antibodies/vac-
cines’, 23.8% about ‘pathophysiology/epidemiology/ecology’, 
8.9% about ‘preparedness’, 6.9% about ‘society/policy/ethics’ and 
3.0% about ‘other’ areas of study. We also looked at how many of 
these papers were specifically focused on specific aspects of the 
current West Africa outbreak. We observed that 13.9% of the papers 
dealt with some features of the 2014 epidemic. In this case, differ-
ently from before, the papers were (optionally) assigned to the ‘out-
break’ category in addition to the assignment to the discipline/area 
categories (Figure S34) (sheet 8). The pattern of discipline/area 
focus of the papers were different between the two countries, with 
the United States pattern more similar to the average pattern, as also 
anticipated by the much higher share of publications published by 
the United States. These results indicate that, differently from the 
papers without abstracts (e.g. editorials, commentaries, short letters), 
research papers and extensive reviews focus much more on basic 
cell and molecular biology or on drugs and vaccines and less on 
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preparedness or on specific aspects of the current epidemic (see also 
USA and Canada sheets).
A look at the Ebola literature from the three countries most 
affected by the 2014 epidemic
We then looked at the publication output of the three countries 
(Sierra Leone, Liberia and Guinea) that have been most affected 
by the epidemic, both in terms of cases and deaths (http://www.
cdc.gov/vhf/ebola/outbreaks/2014-west-africa/case-counts.html). 
We therefore calculated the total numbers of biomedical papers 
as well as the only papers on Ebola, taking also in consideration 
only publications with an abstract available. These countries pub-
lish very low numbers of biomedical papers: in 2014, 46 by Sierra 
Leone, 14 by Liberia and 45 by Guinea. All three countries had a 
high proportion of papers with an abstract available similarly to 
the 20 countries with most publications (the average was 83.6%). 
Despite the very small numbers of total biomedical publications, 
all the three countries published papers on Ebola. Sierra Leone had 
4 publications with an abstract available, Liberia 4 and Guinea 2 
(Figure S35) (sheet 9). As expected, the Ebola ‘attraction scores’ 
for these three countries were very high (sheet 9). As done before, 
we also controlled for the accuracy of our method for the 10 papers 
with an abstract available retrieved by searching the affiliation 
field. Nine of these papers (90% of cases) were authored by at least 
one person with (at least) an affiliation in one of three countries. 
This confirmed again the accuracy of our method as only 1 out 
of total 165 tested papers (so 0.6% of the tested papers) did not 
have any author with an affiliation truly corresponding to the 
searched country. We also determined the numbers of first authors 
and last authors that had a reported affiliation in the searched 
country. While there were no publications with the first or the last 
author with a Liberia affiliation, there were 2 publications with the 
first author having a Sierra Leone affiliation, 2 publications with 
the first author having a Guinea affiliation, 2 publications with the 
last author having a Sierra Leone affiliation and 2 publications with 
the last author having a Guinea affiliation (Figure S36) (sheet 9). 
Among the 9 papers with at least one author from one of these three 
countries, 7 focused on some aspects of the 2014 epidemic. There 
were also 5 original research articles but 4 of these had neither the 
first nor the last author from one of the three countries. The only 
research article with either the first or last author with an affilia-
tion in one of the three countries was a paper from Guinea of the 
category ‘pathophysiology/epidemiology/ecology’ (see also Sierra 
Leone, Liberia and Guinea sheets).
Conclusions
In this report we have analyzed the volumes and characteristics of 
the publications about Ebola virus during the year 2014. These are 
some of the key findings: 
1. There were 900 citations with the terms ‘Ebola’ or ‘Ebolavi-
rus’ in the title/abstract, including 797 citations with one of 
these terms in the title.
2. The volume of citations was over 12-fold the volume of 
citations of 2013.
3. The volume of citations with an abstract available was over 
4-fold the volume of citations of 2013.
4. The proportion of papers with an abstract available was 
32.9% whereas in 2013 it was 92.4%. The proportion for 
all biomedical papers published by the top 20 publishing 
countries was 91.3%.
5. 20.6% of the papers with an abstract available contained the 
terms ‘vaccine’ or vaccines’ in the title/abstract.
6. 46.2% of the papers with an abstract available contained the 
term ‘Africa’ in the title/abstract.
7. There were only 2 publications about an original clinical 
trial study.
8. 85.4% of the papers were published in the last 4 months of 
the year.
9. 81.6% of the papers with an abstract available were pub-
lished in the last 4 months of the year.
10. The peak of papers with the term ‘outbreak’ in the title/
abstract was in October.
11. The country with most publications on Ebola was the United 
States with 122 citations, followed by the United Kingdom 
with 64 citations.
12. The country with most publications on Ebola with an 
abstract available was the United States with 80 citations, 
followed by Canada with 21 citations.
13. Among the 80 publications with an abstract available and 
with at least one author affiliated to a United States insti-
tution, the first and last authors with an affiliation in this 
country were 67 and 72, respectively.
14. Among publications with an abstract available and with 
either United States or Canada affiliations, 68.3% were 
original research papers.
15. Among publications with an abstract available and with 
either United States or Canada affiliations, 27.7% were 
studies about ‘drugs/antibodies/vaccines’ and 29.7% were 
other types of ‘cell/molecular biology’ studies.
16. There were 9 publications with an abstract available with at 
least one author with an affiliation in Sierra Leone, Liberia or 
Guinea, including 4 with either the first or the last author with 
an affiliation in these countries. There were also 5 original 
research papers with at least one author from these countries.
The data of this report show a very dramatic change in the vol-
ume and nature of Ebola publications in 2014. While non-research 
papers have played a major role in the staggering increase in publi-
cations, there has also been a dramatic increase of original research 
articles or research notes (like this same research note), including 
many studies on potential new drugs or vaccines or related to basic 
biological research. Interestingly, the increase in publications took 
place in the second part of 2014 although the epidemic had already 
started at the end of 2013. The surge in publications (research and 
non-research papers) was therefore concomitant with the surge in 
number of cases and deaths and thus certainly due to the current 
West Africa outbreak. Even if an analysis of the causes is beyond 
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the scope of this note, this surge could be due to several reasons: 
a genuine increased interest towards a major global health threat, 
a perception of easiness in publishing by writing about Ebola or 
by simply inserting a few comments on Ebola in the title/abstract, 
a strategic move in anticipation of increased funding for the Ebola 
field and several other reasons. Anyway, the findings of this research 
note shows that the scientific community started publishing many 
more editorials, letters and comments on Ebola only during or after 
the massive increase in deaths and media coverage. Even if the 
rises in scientific papers and media coverage could be independ-
ent, it can be speculated that at least a fraction of them were in fact 
inter-dependent. In particular, it is plausible that many scientific 
publications were conceived and published as a consequence of the 
extensive coverage in news and social media. Future studies will 
shed more light on the relationship between media coverage and 
scientific publications during the 2014 Ebola outbreak or similar 
worldwide threats.
The data presented in this report and in future studies will be use-
ful to better comprehend how the scientific community responds 
to this kind of global health threats with massive media coverage. 
This information will assist scholars, public health officials and 
policymakers in their efforts to improve scientific research poli-
cies with the goal of maximizing both public health and knowledge 
advancement.
Additional methodological notes
Publication output was determined by using the free and pub-
lic search engine PubMed. All searches were performed during 
February 2015. All data and searching details are included in 
the accompanying database containing ‘sheets 1–9’, the ‘clinical 
trial term’ sheet, and the ‘Canada’, ‘China’, ‘France’, ‘Germany’, 
‘Guinea’, ‘Liberia’, ‘Sierra Leone’, ‘UK’ and ‘USA’ sheets.
Data availability
Figshare: Dataset and selected figures of biomedical publications 
on Ebola in 2014. doi: 10.6084/m9.figshare.132848313
Author contributions
Andrea Ballabeni designed the research, collected the data, ana-
lyzed the results and wrote the manuscript. Andrea Boggio analyzed 
the results and wrote the manuscript. All authors approved the final 
manuscript for publication.
Competing interests
No competing interests were disclosed.
Grant information
The author(s) declared that no grants were involved in supporting 
this work.
Supplementary figures
Figure S1. Numbers of 2014 citations with ‘ebola’ or ‘ebolavirus’ in title, title/abstract or all fields.
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Figure S2. Number of 2014 citations with ‘ebola’ vs ‘ebolavirus’ in title field.
Figure S3. Numbers of citations with ‘ebola’ or ‘ebolavirus’ in title from 1995 to 2014.
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Figure S4. Numbers of citations (abstract available) with ‘ebola’ or ‘ebolavirus’ in title from 1995 to 2014.
Figure S5. Proportions of citations (‘ebola’ or ‘ebolavirus’ in title) with abstract available from 2005 to 2014.
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Figure S6. Proportions of citations (‘ebola’ or ‘ebolavirus’ in title) by different PubMed ‘article type’ filters. Year 2014.
Figure S7. Proportions of citations (‘ebola’ or ‘ebolavirus’ in title) with abstract available by different PubMed ‘article type’ filters. 
Year 2014.
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Figure S8. Proportions of citations (‘ebola’ or ‘ebolavirus’ in title) in English, by text availability and by presence of PubMed Commons 
comments. Year 2014.
Figure S9. Proportions of citations (‘ebola’ or ‘ebolavirus’ in title) with abstract available in English, by text availability and by presence 
of PubMed Commons comments. Year 2014.
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Figure S10. Proportions of ‘article journal’ citations (‘ebola’ or ‘ebolavirus’ in title) in English, by text availability and by presence of 
PubMed Commons comments. Year 2014.
Figure S11. Proportion of citations (‘ebola’ or ‘ebolavirus’ in title) with abstract available that are ‘journal articles’ and proportion of 
‘journal article’ citations (‘ebola’ or ‘ebolavirus’ in title) that have an abstract available. Year 2014.
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Figure S12. Proportions of citations (‘ebola’ or ‘ebolavirus’ in title) with the indicated search terms in the title/abstract. Year 2014.
Figure S13. Proportions of citations (‘ebola’ or ‘ebolavirus’ in title) with the indicated search terms in the title/abstract. Year 2014.
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Figure S14. Proportions of citations (‘ebola’ or ‘ebolavirus’ in title) with abstract available with the indicated search terms in the title/
abstract. Year 2014.
Figure S15. Proportions of citations (‘ebola’ or ‘ebolavirus’ in title) with abstract available with the indicated search terms in the title/
abstract. Year 2014.
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Figure S16. Proportions of citations (‘ebola’ or ‘ebolavirus’ in title) with the search term ‘clinical trial’ in the title/abstract. The number 
of publications about original clinical trial studies is also indicated. Year 2014.
Figure S17. Numbers of citations (‘ebola’ or ‘ebolavirus’ in title) per month. Year 2014.
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Figure S18. Numbers of citations (‘ebola’ or ‘ebolavirus’ in title) with abstract available per month. Year 2014.
Figure S19. Subjective classification for ‘current outbreak’ focus of 2014 citations (‘ebola’ or ‘ebolavirus’ in title). Remaining citations 
were assigned to one (and only one) of the indicated discipline/area categories. Year 2014.
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Figure S20. Subjective classification for current outbreak focus or, alternatively, for the indicated discipline/area categories of 2014 
citations (‘ebola’ or ‘ebolavirus’ in title) per month. Citations were assigned to one (and only one) category, similarly to Figure S19. 
Year 2014.
Figure S21. Numbers of citations (‘ebola’ or ‘ebolavirus’ in title) during 2014 with search term ‘outbreak’ in title/abstract.
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Figure S22. Numbers of citations (‘ebola’ or ‘ebolavirus’ in title) during 2014 with search term ‘Africa’ in title/abstract.
Figure S23. Numbers of citations (‘ebola’ or ‘ebolavirus’ in title) during 2014 with search terms ‘vaccine’ or ‘vaccines’ in title/abstract.
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Figure S24. Numbers of total biomedical citations of the 20 countries with most total biomedical publications. Year 2014.
Figure S25. Numbers of citations (‘ebola’ or ‘ebolavirus’ in title) of the 20 countries with most total biomedical publications. Year 
2014.
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Figure S26. ‘Attraction scores’ for citations (‘ebola’ or ‘ebolavirus’ in title) of the 20 countries with most total biomedical publications. 
‘Attraction scores’ were calculated by dividing the number of Ebola-related citations by the total biomedical citations of the country and by 
multiplying by 10,000. Year 2014.
Figure S27. Proportions of total citations with abstract available of the 20 countries with most total biomedical publications. 
Year 2014.
Page 19 of 28
F1000Research 2015, 4:68 Last updated: 09 OCT 2015
Figure S28. Numbers of total citations with abstract available of the 20 countries with most total biomedical publications. Year 2014.
Figure S29. Numbers of citations (‘ebola’ or ‘ebolavirus’ in title) with abstract available of the 20 countries with most total biomedical 
publications. Year 2014.
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Figure S30. ‘Attraction scores’ for citations (‘ebola’ or ‘ebolavirus’ in title) with abstract available of the 20 countries with most 
total biomedical publications. ‘Attraction scores’ were calculated by dividing the number of Ebola-related citations by the total biomedical 
citations of the country and by multiplying by 10,000. Year 2014.
Figure S31. Numbers of citations (‘ebola’ or ‘ebolavirus’ in title) of the six countries with most Ebola-related publications. Citations 
(‘ebola’ or ‘ebolavirus’ in title) with abstract available are also shown. Year 2014.
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Figure S32. ‘Manual’ control test of the method for country affiliation attribution. Numbers of citations (‘ebola’ or ‘ebolavirus’ in title) with 
abstract available of the six countries with most Ebola-related publications. The numbers of publications automatically retrieved or with real 
‘any author’, ‘first author’ or ‘last author’ with the proper country affiliation are indicated. 100% of the citations had at least one author (‘any 
author’) with the proper country affiliation, thus indicating accuracy of the method. Year 2014.
Figure S33. Subjective classification for article type of citations (‘ebola’ or ‘ebolavirus’ in title) with abstract available of the United 
States and Canada, the two countries with most Ebola-related publications with abstract available. Year 2014.
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Figure S34. Subjective classification for discipline/area of citations (‘ebola’ or ‘ebolavirus’ in title) with abstract available of the United 
States and Canada, the two countries with most Ebola-related publications with abstract available. Citations were assigned only to the 
more relevant category, except citations related to specific aspects of the 2014 outbreak that were assigned optionally and in addition to the 
other categories. Year 2014.
Figure S35. Numbers of total biomedical citations and citations (‘ebola’ or ‘ebolavirus’ in title) of Sierra Leone, Liberia and Guinea, the 
three countries with most Ebola cases. Year 2014.
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Figure S36. ‘Manual’ control test of the method for country affiliation attribution. Numbers of citations (‘ebola’ or ‘ebolavirus’ in title) with 
abstract available of the three countries with most Ebola cases. The numbers of publications automatically retrieved or with real ‘any author’, 
‘first author’ or ‘last author’ with the proper country affiliation are indicated. Year 2014.
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 Ann Kelly
Department of Sociology, Philosophy and Anthropology, University of Exeter, Exeter, UK
The sheer volume of Ebola Virus Disease (EVD) scholarship published over the past year is
unprecedented in the forty-year history of the disease. This paper provides a close examination of what is
reported as an ‘over 12-fold’ increase in biomedical output, scrutinizing trends in publication content,
authorship, disciplinary orientations and institutional origins, as well as availability. A central conclusion of
this analysis is that EVD-literature surges in late 2014, coinciding with both the peak of the outbreak in
West Africa and media attention.
The paper benefits from a robust methodological approach; the search criteria are well considered and
rigorously applied. Some further detail about the timelines for publication might have been useful: for
instance, how long from submission would a research article take to be published, and whether different
timeframes exist for research as opposed to commentary pieces. This further analysis might qualify the
claims regarding the simultaneity of the volume of publications and the dramatic rise in Ebola cases.
That being said, the granularity of the sub-analysis—e.g. assessing the number of papers authored by
researchers affiliated with institutions in West Africa—generates some intriguing insights into the shifts in
scientific interest from basic Ebola science to the specific features of the current outbreak, and suggests
some of the constraints of scientific collaborations in countries with weak research infrastructure. The
subject analysis also offers some tantalizing leads into the prominence of certain research areas—for
instance vaccines—during a time a global health crisis.
My central reservation is that these connections are not explored further. The general point that media
coverage and research agendas are inter-related seems hardly surprising. Indeed, scholarship in
scientific communication and science and technology studies has illuminated these links as well as the
politics of funding in considerable detail. With such a potentially rich dataset to hand, it is frustrating that
the authors are not more ambitious in their interpretations, comparing for instance, a similar set of trends
in the literature published during the Avian Flu or SARS epidemics. Has the emphasis on ‘preparedness’
shifted? In what ways has the institutional geography of authorship changed?
In general, this is an intriguing article that offers a solid overview on the dynamics of scientific output in
response to a global threat. My only regret is that the analytical agenda was not bolder, for it could have
led to a few more surprising conclusions. 
I have read this submission. I believe that I have an appropriate level of expertise to confirm that
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I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard, however I have significant reservations, as outlined
above.
 No competing interests were disclosed.Competing Interests:
Author Response 21 Sep 2015
, Harvard School of Public Health, USAAndrea Ballabeni
We would like to thank Dr Ann Kelly for her review. We are glad for her appreciation of the paper
and want to address her two concerns.
 
The comment “how long from submission would a research article take to be published, and
” is a very goodwhether different timeframes exist for research as opposed to commentary pieces
one. Indeed we agree with the referee that these timeframes must be taken in consideration and
added a short discussion in the Conclusions section to address this concerns. However, we think
that an in-depth quantitative analysis of this topic is complex and not suitable for the purposes and
length-constraints of this short “research note.” Future studies will certainly shed more light on
these timeframes.
 
With regard to the comment: “scholarship in scientific communication and science and technology
studies has illuminated these links as well as the politics of funding in considerable detail. With
such a potentially rich dataset to hand, it is frustrating that the authors are not more ambitious in
their interpretations, comparing for instance, a similar set of trends in the literature published during
the Avian Flu or SARS epidemics. Has the emphasis on ‘preparedness’ shifted? In what ways has
”the institutional geography of authorship changed?
We agree with the referee that it would be very interesting to perform these additional
investigations. For this reason we have added a short discussion in the Conclusions section.
However, though potentially informative, these additional analyses were beyond the purposes and
the length-constraints of this short research note. Even if we certainly agree that it will be worth
performing these investigations in future studies, we hope that the referee concurs that the lack of
these further analyses does not diminish the quality of the data presented in this research note. In
fact the scope of the “research note” was to provide a set of good data to be used in and to
stimulate further and broader studies.
We hope that, based on this clarification, the referee can now fully approve our article.
 
Moreover, we have made a few additional changes (summarized in Amendments from Version 1
box) that hopefully will be appreciated by the referee.
 
We would like to thank again Dr Kelly for her thoughtful and helpful comments.
 
Best regards,
Andrea Ballabeni and Andrea Boggio 
 No competing interests were disclosed.Competing Interests:
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 17 March 2015Referee Report
doi:10.5256/f1000research.6655.r7968
 Alfonso Rodriguez-Morales
Faculty of Health Sciences, Universidad Tecnológica de Pereira, Pereira, Colombia
Very interesting article.
General comments:
The appropriateness of the title: Ok.
Whether the abstract provides an adequate summary of the article: I would include the total
number of articles found in the abstract.
If there is a comprehensive explanation of study design, methods and analysis, and their suitability
to the investigation: Ok.
Whether the conclusions are balanced and justified on the basis of the results: I suggest
commenting more on the implications of the findings in regard the advance to obtain an available
vaccine for Ebola.
With regards to the data (if applicable), whether sufficient information has been provided for
replication of the experiment, and/or if the data are in a usable format: Ok.
I have only two recommendations:
To further discuss why the authors only assessed the database PubMED/Medline, and
why Science Citation Index and Scopus were not included. Even we can consider to include also
some African database.
 
V1 of this article appears online on March 13, 2015, however, 7 days before, on March 6, 2015,
appeared online the following article:
Cruz-Calderón S, Nasner-Posso KM, Alfaro-Toloza P, Paniz-Mondolfi AE, Rodríguez-Morales AJ. 
. 2015A bibliometric analysis of global Ebola research Travel Medicine & Infectious Disease 
Epub Ahead Mar 6; available online at: 
. doi:http://www.sciencedirect.com/science/article/pii/S1477893915000344
10.1016/j.tmaid.2015.02.007.
Then, I consider this should be cited, as a preliminary approach to this topic. Also comparing the
findings between both. This analysis included PubMED/Medline, Science Citation Index and
Scopus.
I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard.
 No competing interests were disclosed.Competing Interests:
Author Response 05 Oct 2015
, Harvard School of Public Health, USAAndrea Ballabeni
We would like to thank Dr Alfonso Rodriguez-Morales for his review. We are glad the referee likes
and approves our article. Here are our responses to his comments/suggestion.
 
As suggested by the referee, we have now included the number of total publications in the
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As suggested by the referee, we have now included the number of total publications in the
abstract, based on an updated search performed in September 2015.
With reference to the implication of the findings in regard to the advances to obtain a vaccine, we
think this is a more complex topic that is beyond the purpose of this short research note. However,
we certainly agree with the referee that this is an important issue that would be worth
investigating/discussing in future studies and opinion pieces.
 
With regard to the two recommendations:
We think that given the comprehensiveness and breadth of the PubMed-searched
databases, the results presented in this paper are a bona fide representation of the
literature. In any case, even if this is beyond the scope of this short research note, we agree
with the referee that it could be useful to confirm these data by using also other databases
such as the Web of Science (Thomson Reuter) and the Scopus (Elsevier). To address this,
we have added a few comments in the Conclusions section. Moreover, to emphasize that
the data presented in this paper are based on PubMed-searches we have modified the
title.Moreover, we believe that the fact that this paper is based on a search
engine/databases that is free and easily accessible adds value to the results.
 
We have added the reference suggested and authored by the referee. We think that this
referenced paper, published a few days before our paper, indeed provides interesting
information that supports and complements the data of our study. We have also added a
short comment in the Conclusions section. 
Moreover, we have made a few additional changes (summarized in Amendments from Version 1
box) that hopefully will be appreciated by the referee.
 
We would like to thank again Dr Rodriguez-Morales for his advice.
 
Best regards,
Andrea Ballabeni and Andrea Boggio 
 No competing interests were disclosed.Competing Interests:
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